Stoke Therapeutics (STOK) Other Gross PP&E Adjustments (2022 - 2025)
Historic Other Gross PP&E Adjustments for Stoke Therapeutics (STOK) over the last 4 years, with Q3 2025 value amounting to -$5.4 million.
- Stoke Therapeutics' Other Gross PP&E Adjustments rose 1850.95% to -$5.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.4 million, marking a year-over-year increase of 1850.95%. This contributed to the annual value of $7.3 million for FY2024, which is 566.96% down from last year.
- As of Q3 2025, Stoke Therapeutics' Other Gross PP&E Adjustments stood at -$5.4 million, which was up 1850.95% from -$4.3 million recorded in Q2 2025.
- Stoke Therapeutics' Other Gross PP&E Adjustments' 5-year high stood at $7.7 million during Q4 2023, with a 5-year trough of -$7.8 million in Q1 2024.
- Over the past 4 years, Stoke Therapeutics' median Other Gross PP&E Adjustments value was -$5.3 million (recorded in 2025), while the average stood at -$3.2 million.
- In the last 5 years, Stoke Therapeutics' Other Gross PP&E Adjustments tumbled by 8283.02% in 2024 and then skyrocketed by 4420.76% in 2025.
- Stoke Therapeutics' Other Gross PP&E Adjustments (Quarter) stood at $5.6 million in 2022, then surged by 38.17% to $7.7 million in 2023, then fell by 5.67% to $7.3 million in 2024, then plummeted by 173.66% to -$5.4 million in 2025.
- Its Other Gross PP&E Adjustments was -$5.4 million in Q3 2025, compared to -$4.3 million in Q2 2025 and -$5.3 million in Q1 2025.